Molecular structural characteristics as determinants of estrogen receptor selectivity.

Recent reports that a wide variety of natural and man-made compounds are capable of competing with natural hormones for estrogen receptors serve as timely examples of the need to advance screening techniques to support human health and ascertain ecological risk. Quantitative structure-activity relationships (QSARs) can potentially serve as screening tools to identify and prioritize untested compounds for further empirical evaluations. Computer-based QSAR molecular models have been used to describe ligand-receptor interactions and to predict chemical structures that possess desired pharmacological characteristics. These have recently included combined and differential relative binding affinities of potential estrogenic compounds at estrogen receptors (ER) alpha and beta. In the present study, artificial neural network (ANN) QSAR models were developed that were able to predict differential relative binding affinities of a series of structurally diverse compounds with estrogenic activity. The models were constructed with a dataset of 93 compounds and tested with an additional dataset of 30 independent compounds. High training correlations (r2=0.83-0.91) were observed while validation results for the external compounds were encouraging (r2=0.62-0.86). The models were used to identify structural features of phytoestrogens that are responsible for selective ligand binding to ERalpha and ERbeta. Numerous structural characteristics are required for complexation with receptors. In particular, size, shape and polarity of ligands, heterocyclic rings, lipophilicity, hydrogen bonding, presence of quaternary carbon atom, presence, position, length and configuration of a bulky side chain, were identified as the most significant structural features responsible for selective binding to ERalpha and ERbeta.

[1]  Gerald T. Ankley,et al.  Quantitative structure‐activity relationships for polychlorinated hydroxybiphenyl estrogen receptor binding affinity: An Assessment of conformer flexibility , 1996 .

[2]  Arja Asikainen,et al.  Spectroscopic QSAR Methods and Self-Organizing Molecular Field Analysis for Relating Molecular Structure and Estrogenic Activity , 2003, J. Chem. Inf. Comput. Sci..

[3]  John A. Katzenellenbogen,et al.  The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site , 1997, Steroids.

[4]  K E Carlson,et al.  Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. , 1997, Biochemistry.

[5]  B. Katzenellenbogen,et al.  Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes. , 2003, Bioorganic & medicinal chemistry.

[6]  Artificial neural network modelling of phytoestrogen binding to estrogen receptors , 2006 .

[7]  Wolfgang Sippl,et al.  Receptor-based 3D QSAR analysis of estrogen receptor ligands – merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods , 2000, J. Comput. Aided Mol. Des..

[8]  F. Burden.  Molecular identification number for substructure searches , 1989, J. Chem. Inf. Comput. Sci..

[9]  Weida Tong,et al.  QSAR Models Using a Large Diverse Set of Estrogens , 2001, J. Chem. Inf. Comput. Sci..

[10]  B. Busetta,et al.  17β‐Hydroxymethyl‐1,3,5(10)‐estratrien‐3‐ol monohydrate , 1980 .

[11]  Markus A Lill,et al.  Raptor: combining dual-shell representation, induced-fit simulation, and hydrophobicity scoring in receptor modeling: application toward the simulation of structurally diverse ligand sets. , 2004, Journal of medicinal chemistry.

[12]  J. Gustafsson,et al.  Biological Role of Estrogen and Estrogen Receptors , 2002, Critical reviews in biochemistry and molecular biology.

[13]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.

[14]  David A. Agard,et al.  Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism , 2002, Nature Structural Biology.

[15]  B. Katzenellenbogen,et al.  Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.

[16]  B. Katzenellenbogen,et al.  Editorial: A New Actor in the Estrogen Receptor Drama-Enter ER-β. , 1997, Endocrinology.

[17]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Marjana Novic,et al.  Variable Selection and Interpretation in Structure-Affinity Correlation Modeling of Estrogen Receptor Binders , 2005, J. Chem. Inf. Model..

[19]  O. Mekenyan,et al.  Development and validation of an average mammalian estrogen receptor-based QSAR model , 2002, SAR and QSAR in environmental research.

[20]  Y. Ouchi,et al.  The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. , 1998, Biochemical and biophysical research communications.

[21]  Robert S. Pearlman,et al.  Metric Validation and the Receptor-Relevant Subspace Concept , 1999, J. Chem. Inf. Comput. Sci..

[22]  Juhani Ruuskanen,et al.  Consensus kNN QSAR: a versatile method for predicting the estrogenic activity of organic compounds in silico. A comparative study with five estrogen receptors and a large, diverse set of ligands. , 2004, Environmental science & technology.

[23]  Donald F. Specht,et al.  A general regression neural network , 1991, IEEE Trans. Neural Networks.

[24]  J. Balasch.  Sex steroids and bone: current perspectives. , 2003, Human reproduction update.

[25]  J. Katzenellenbogen,et al.  Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor. , 2001, Bioorganic & medicinal chemistry.

[26]  Anton J. Hopfinger,et al.  Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[27]  W. A. Toscano,et al.  QSAR Models of the in vitro Estrogen Activity of Bisphenol A Analogs , 2003 .

[28]  B. Katzenellenbogen,et al.  The nature of the ligand-binding pocket of estrogen receptor alpha and beta: The search for subtype-selective ligands and implications for the prediction of estrogenic activity , 2003 .

[29]  M. Alexis,et al.  A new class of phytoestrogens; evaluation of the estrogenic activity of deoxybenzoins. , 2004, Chemistry & biology.

[30]  Tudor I. Oprea,et al.  MTD-PLS: A PLS Variant of the Minimal Topologic Difference Method. III. Mapping Interactions between Estradiol Derivatives and the Alpha Estrogenic Receptor , 2005, J. Chem. Inf. Model..

[31]  N. Copeland,et al.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. , 1997, Molecular endocrinology.

[32]  F. Schueler.  Sex Hormonal Action and Chemical Constitution. , 1946, Science.

[33]  Weida Tong,et al.  Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts. , 2001, Environmental health perspectives.

[34]  L. Gray,et al.  Tiered screening and testing strategy for xenoestrogens and antiandrogens. , 1998, Toxicology letters.

[35]  B. Katzenellenbogen,et al.  Synthesis and biological evaluation of a novel series of furans: Ligands selective for estrogen receptor α , 2001 .

[36]  B. Katzenellenbogen,et al.  Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction. , 2000, Bioorganic & medicinal chemistry.

[37]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[38]  Donald R. Scott,et al.  UNIPALS: Software for principal components analysis and partial least squares regression , 1989 .

[39]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[40]  K E Carlson,et al.  Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. , 1999, Journal of medicinal chemistry.

[41]  F. Burden.  A CHEMICALLY INTUITIVE MOLECULAR INDEX BASED ON THE EIGENVALUES OF A MODIFIED ADJACENCY MATRIX , 1997 .

[42]  B. Katzenellenbogen,et al.  Characterization of the Biological Roles of the Estrogen Receptors, ERα and ERβ, in Estrogen Target Tissues in Vivo through the Use of an ERα-Selective Ligand , 2002 .

[43]  B. Katzenellenbogen,et al.  Antagonists Selective for Estrogen Receptor ␣ , 2022 .

[44]  Eva Enmark,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Human Estrogen Receptor �-Gene Structure, Chromosomal Localization, and Expression Pattern* , 2022 .

[45]  B. Zhu,et al.  Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. , 2006, Endocrinology.

[46]  S. Haroutounian,et al.  Synthesis of novel nitro-substituted triaryl pyrazole derivatives as potential estrogen receptor ligands. , 2007, Molecules.